दवाओं की अंतःक्रिया
Abrocitinib + Ticagrelor
गंभीरता: गंभीर
Abrocitinib and Ticagrelor: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Abrocitinib reduces platelet counts, mainly in the early weeks of treatment, and its labeling advises against antiplatelet drugs other than low-dose aspirin during the first 3 months. Adding ticagrelor, a potent P2Y12 inhibitor, to thrombocytopenia increases the risk of significant bleeding.
इस इंटरैक्शन का सरल भाषा में अर्थ
Abrocitinib and Ticagrelor can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Abrocitinib belongs to Miscellaneous; Ticagrelor belongs to Cardiovascular.
ऐसा क्यों होता है
Additive bleeding risk from ticagrelor platelet inhibition combined with abrocitinib-associated reduction in platelet count.
क्या करें
Avoid starting abrocitinib in patients who need ticagrelor during the first 3 months, or choose an alternative therapy. If unavoidable, monitor platelet counts and bleeding signs closely.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Abrocitinib और Ticagrelor की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Ticagrelor के अन्य इंटरैक्शन
- Itraconazole + Ticagrelor निषिद्ध
- Ketoconazole + Ticagrelor निषिद्ध
- Levoketoconazole + Ticagrelor निषिद्ध
- Abciximab + Ticagrelor गंभीर
- Acalabrutinib + Ticagrelor गंभीर
- Acetylsalicylic acid + Ticagrelor गंभीर
Abrocitinib के अन्य इंटरैक्शन
- Abrocitinib + Upadacitinib निषिद्ध
- Abciximab + Abrocitinib गंभीर
- Abrocitinib + Anagrelide गंभीर
- Abrocitinib + Cilostazol गंभीर
- Abrocitinib + Clopidogrel गंभीर
- Abrocitinib + Eptifibatide गंभीर
अक्सर पूछे जाने वाले प्रश्न
Can I take Abrocitinib with Ticagrelor?
MediHelp rates the interaction as major. Abrocitinib and Ticagrelor can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Abrocitinib reduces platelet counts, mainly in the early weeks of treatment, and its labeling advises against antiplatelet drugs other than low-dose aspirin during the first 3 months. Adding ticagrelor, a potent P2Y12 inhibitor, to thrombocytopenia increases the risk of significant bleeding.
How serious is the interaction between Abrocitinib and Ticagrelor?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting abrocitinib in patients who need ticagrelor during the first 3 months, or choose an alternative therapy. If unavoidable, monitor platelet counts and bleeding signs closely.
What other medicines interact with Ticagrelor?
MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
